Thyroid Symptoms in Women: What to Watch For and When to Worry

Thyroid disease is 5-8 times more common in women than men. This is not just statistical; the gender difference is biologically real. The most common thyroid problems — autoimmune thyroid diseases like Hashimoto's thyroiditis and Graves' disease — are more frequent in the female immune profile.

Main reasons: 1) Oestrogen effect — the female hormone oestrogen increases immune-system antibody production; this strengthens the tendency to form autoantibodies against the thyroid. 2) Pregnancy and postpartum — the immune system resets during this period; postpartum thyroiditis affects 5-10% of women in the 6-12 months after delivery. 3) Menopause — falling oestrogen destabilises the thyroid; silent thyroid disease becomes overt during this transition. 4) Genetic predisposition — thyroid disease has stronger heritable transmission in women; mother-to-daughter inheritance is common.

For this reason annual thyroid screening is recommended for women over 35. In women planning pregnancy, thyroid evaluation pre-pregnancy, during pregnancy and post-partum is standard practice. At menopause, thyroid check is paired with lifestyle changes. Related service: our thyroid surgery programme.

Hypothyroidism means the thyroid gland is not producing enough hormone. It is the most common thyroid disease in women — affecting 3-5% of women in the general population, rising to 10-20% over age 60. The commonest cause is Hashimoto's thyroiditis (autoimmune; thyroid antibodies slowly destroy the gland).

Symptoms — an insidious, slowly progressive picture. This is what makes hypothyroidism hard to recognise; symptoms are often dismissed as "ageing" or "stress":

Hyperthyroidism means the thyroid gland is producing excess hormone. Less common in women than hypothyroidism (0.5-1%) but more striking and faster to diagnose. The commonest cause is Graves' disease (autoimmune; antibodies continuously stimulate the thyroid), followed by hormone-producing thyroid nodules (toxic nodule, toxic multinodular goitre).

Symptoms — a rapid-onset, dramatic picture:

A thyroid nodule is a discrete soft-tissue or fluid-filled mass developing within the thyroid gland. 50% of adult women, and 70% over age 60, have thyroid nodules — very common. The great majority (95%) are benign (not cancer).

Most nodules are asymptomatic. They are found incidentally — on routine health check, on a neck ultrasound or CT done for other reasons. Symptomatic nodules: 1) Palpable neck mass (moves on swallowing), 2) Hoarseness (nodule pressing on recurrent laryngeal nerve), 3) Difficulty swallowing (esophageal compression), 4) Breathing difficulty (tracheal compression — in large nodules), 5) Hyperthyroidism symptoms if the nodule produces hormone.

Nodule evaluation algorithm: 1) TSH blood test — functional? 2) Thyroid ultrasound — size, composition (solid, cystic, mixed), TI-RADS classification (1-5; risk score). 3) Fine Needle Aspiration Biopsy (FNAB) — if the nodule is ≥1 cm and TI-RADS 4-5 (intermediate-high risk). FNAB is done under ultrasound guidance, in the office, with local anaesthesia; takes 15 minutes, painless.

FNAB result follows the Bethesda classification: 1) Bethesda I — inadequate sample (repeat). 2) Bethesda II — benign — annual ultrasound follow-up. 3) Bethesda III — atypia of undetermined significance — molecular testing or repeat FNAB. 4) Bethesda IV — follicular neoplasm suspected — surgical planning. 5) Bethesda V — high suspicion of cancer — surgery. 6) Bethesda VI — cancer — surgery.

Thyroid cancer has one of the best prognoses among all cancers — especially papillary type (the commonest, 80% of all thyroid cancers) with 10-year survival around 95-99%. It is a "slow-growing, rarely spreading, treatment-responsive" cancer type.

Thyroid cancer subtypes: 1) Papillary thyroid cancer (PTC) — commonest, best prognosis, tends to spread to lymph nodes but this rarely worsens prognosis significantly. 2) Follicular thyroid cancer (FTC) — less common (10%), spreads via blood, still good prognosis. 3) Medullary thyroid cancer (4%) — produces calcitonin, has a heritable component (MEN-2 syndrome). 4) Anaplastic thyroid cancer (1%) — very aggressive, poor prognosis, fortunately very rare.

Diagnosis is typically by FNAB (Bethesda V or VI). Treatment: surgery (thyroidectomy — total or hemi). Surgery type depends on the cancer: hemi-thyroidectomy (half thyroid removal) for small (<1 cm) papillary cancer; total thyroidectomy for larger or multifocal tumours. Post-surgical radioactive iodine (RAI) is added in some cases.

Post-op quality of life: after total thyroidectomy, lifelong levothyroxine (T4 hormone) replacement is needed — one tablet daily, morning, fasting. With correct dosing, quality of life is normal; sport, career, pregnancy, childbirth — all possible. Women who had thyroid cancer treatment live most of their life without restriction.

Screening: routine thyroid cancer screening is not performed in the general population (no proven benefit). Women with family history (especially medullary type) get genetic testing and annual ultrasound. For the general female population: annual thyroid palpation + 5-yearly ultrasound is a practical Türkiye-context recommendation. Step-by-step details: thyroid nodule page.

Thyroid evaluation follows a simple, hierarchical test logic. Applying steps in order avoids unnecessary tests and unnecessary anxiety.

Step 1: TSH (Thyroid Stimulating Hormone) — a single blood test. Normal TSH means the thyroid is functionally healthy. High TSH suggests hypothyroidism, low TSH suggests hyperthyroidism. This test is often sufficient.

Step 2 (if TSH is abnormal): free T3 and T4 — supporting hormone measurements. Clarifies which type of thyroid disease (subclinical vs overt, primary vs secondary).

Step 3 (if autoimmune suspected): Anti-TPO and Anti-TG antibodies — for Hashimoto's. TSI (thyroid-stimulating immunoglobulin) — for Graves'.

Step 4 (structural evaluation): thyroid ultrasound — size, nodules, cystic features, lymph node assessment. Now a standard test in all thyroid evaluation.

Step 5 (if nodule present): FNAB — ultrasound-guided, office-based. Result reported on the Bethesda classification.

Step 6 (rare): thyroid scintigraphy — functional imaging. Distinguishes hot (hormone-producing) from cold (non-producing) nodules. Cold nodules carry slightly higher cancer risk.

This hierarchy manages test cost and interpretation. Many patients want "all tests, full panel"; a systematic approach is cheaper and more meaningful.

Thyroid evaluation pre-pregnancy, during pregnancy and post-partum is standard practice. The reason: thyroid hormone is critical for fetal brain development — especially in the first 12 weeks, when the fetus depends on maternal thyroid hormone (own thyroid does not function yet).

Pre-pregnancy: TSH check — ideal TSH <2.5 mIU/L; if high, levothyroxine is started and TSH brought to this range before pregnancy.

During pregnancy: first-trimester TSH — hormone need increases 30-50% (especially in women with Hashimoto's history). Levothyroxine dose is increased through pregnancy. TSH is checked every 4-6 weeks in the second and third trimesters.

Post-partum: postpartum thyroiditis occurs in 5-10% of women (especially Anti-TPO positive). First phase is hyperthyroidism (1-6 months postpartum), second phase hypothyroidism (6-12 months). Most cases spontaneously resolve but some women develop permanent hypothyroidism. Postpartum TSH is checked at 3 and 6 months.

Thyroid evaluation in pregnant or pregnancy-planning women is coordinated with the family doctor, endocrinologist or obstetrician; the ENT surgeon enters only when surgery is needed (large nodule, suspected cancer).

Menopause is the period in a woman's life when thyroid disease "surfaces". Previously silent (subclinical) thyroid problems become overt when combined with menopausal physiology.

Mechanism: oestrogen decline at menopause has two effects — 1) Changes thyroid hormone metabolism (affecting T4-to-T3 conversion), 2) Resets the immune system, accelerating silent autoimmune processes.

Clinical consequence: common menopausal symptoms (fatigue, weight gain, mood changes, sleep disturbance, hot flushes) overlap significantly with hypothyroid symptoms. Thyroid function tests are essential to distinguish.

A woman over 40 saying "I am tired, gaining weight, my hair is falling" should be evaluated for both menopause and thyroid. They can co-occur — menopause slows metabolism while concurrent hypothyroidism amplifies the picture. Thyroid hormone replacement in this scenario can produce dramatic improvement.

Recommendation: annual TSH check for all women over 40; every 6 months from age 60+. Cheap, simple, life-quality-preserving screening.

Thyroid disease is mostly managed by endocrinology — medical treatment (levothyroxine, antithyroid drugs, radioactive iodine) is the endocrinologist's domain. ENT / head-and-neck surgery enters only when surgery is needed.

Surgical indications: 1) Thyroid cancer (FNAB-confirmed). 2) Large nodule requiring surgery (>4 cm, pressure symptoms). 3) Uncontrolled hyperthyroidism — total thyroidectomy in patients not responding to antithyroid drugs or unsuitable for radioactive iodine. 4) Cosmetic indication — large goitre or visible neck deformity. 5) Indeterminate FNAB (Bethesda III or IV) — surgery if needed after molecular testing.

Surgical options: 1) Hemi-thyroidectomy (lobectomy) — half the thyroid is removed. For unilateral nodule or small cancer. Hormone replacement usually not needed (remaining half makes sufficient hormone). 2) Total thyroidectomy — the entire thyroid is removed. For multifocal tumour, advanced cancer, uncontrolled hyperthyroidism. Lifelong levothyroxine required.

Complication risks: low in an experienced head-and-neck surgeon but real — recurrent laryngeal nerve injury (1-3%), hypoparathyroidism (1-5% temporary, 0.5-2% permanent), bleeding, infection. Hence surgeon selection is critical; surgeons doing at least 60 thyroid cases per year are preferred.

Prof. Dr. Hasan Ahmet Özdoğan's subspecialty areas include thyroid and head-and-neck surgery; thousands of thyroid surgeries performed over 30+ years. Related reading: our Istanbul thyroid surgery page.